Impact of genetic deletion of MrgD or Mas receptors in depressive-like behaviour in mice

• Published in: Acta neuropsychiatrica 2023-02, Vol.35 (1), p.27-34
• Main Authors: Becari, Luca, Fonseca, Maria Luiza A, Gonçalves, Sthéfanie C A, Bader, Michael, Santos, Robson A S, Campagnole-Santos, Maria José, Kangussu, Lucas M
• Format: Article
• Language: English
• Subjects: Animals; Anxiety; Blood pressure; Brain; Brain-derived neurotrophic factor; Brain-Derived Neurotrophic Factor - genetics; Brain-Derived Neurotrophic Factor - metabolism; Depression - genetics; Depression - metabolism; Enzymes; Hindlimb Suspension; Hippocampus - metabolism; Kinases; Male; Mice; Mice, Inbred C57BL; Neurobiology; Neurosciences; Prefrontal Cortex - metabolism; Proteins
• ISSN: 0924-2708; 1601-5215
• DOI: 10.1017/neu.2022.20

To evaluate the impact of genetic deletion of receptors of the counterregulatory arms of the renin-angiotensin system in depressive-like behaviours. 8-12 weeks-old male mice wild type (WT, C57BL/6J) and mice with genetic deletion of MrgD (MrgD KO) or Mas receptors (Mas KO) were subjected to the Forced Swim Test (FST) and the Tail Suspension Test (TST). Brain-derived neurotrophic factor (BDNF) levels were measured by enzyme-linked immunosorbent assay (ELISA). Blockade of Mas was performed by acute intracerebroventricular ( ) injection of its selective antagonist, A779. No statistical difference in immobility time was observed between MrgD KO and WT male animals subjected to FST and TST. However, acute injection of A779 significantly increased the immobility time of MrgD KO male mice subjected to FST and TST, suggesting the involvement of Mas in preventing depressive-like behaviour. Indeed, Mas KO male animals showed increased immobility time in FST and TST, evidencing a depressive-like behaviour in these animals, in addition to a reduction in BDNF levels in the prefrontal cortex and hippocampus. No changes in BDNF levels were observed in MrgD KO male animals. Our data showed that Mas plays an important role in the neurobiology of depression probably by modulating BDNF expression. On the contrary, lack of MrgD did not alter depressive-like behaviour, which was supported by the lack of alterations in BDNF levels.